welcome

Hi visitor,
Thank you for visiting my blog. I highly appreciate if you could leave a comment on the site in general or any particular post. It would be helpful for me and other followers.
Showing posts with label neurologic. Show all posts
Showing posts with label neurologic. Show all posts

Monday, January 5, 2015

Anaesthetic management of a case of idiopathic intracranial hypertension

Anaesthetic management of a case of idiopathic intracranial hypertension

INTRODUCTION

Idiopathic intracranial hypertension (IIH) was first described in 1893. Patients with IIH have a classical picture of headache, papilledema, and a raised cerebrospinal fluid (CSF) pressure of more than 25 mmHg. It is more common in women than in men (3:1) with the highest incidence seen in obese women of reproductive age group (20-45 years). The most common presenting symptoms are manifestations of generalized intracranial hypertension, normally headache and visual obscuration. Diplopia, pulsatile tinnitus, nausea and vomiting may be present in about 50% of patients, with neck/back/shoulder pain or radicular pain less frequent.[] The major risk of IIH is visual loss, which may be permanent despite medical therapy. It seems that the symptoms worsen during pregnancy in 50% of the patients and usually resolve postpartum.[]

CASE REPORT

A 45-year-old female, weighing 70 kg presented with complaints of headache, menorrhagia and pain in the abdomen was admitted to our hospital. She was posted for transcervical resection of the endometrium and patient had a past history of headache and blurring of vision 2 years ago and was diagnosed to have IIH and was on tablet acetazolamide 250 mg every 6 h. She had a history of lumbar CSF drainage twice. Patient had a history of hypertension and was on tablet atenolol once daily. On pre-operative examination, pulse was 70/min and blood pressure was under control. Other general and systemic examination was normal. All other investigations were within normal limits. Computer tomography brain was normal and magnetic resonance imaging revealed partially empty sella and no pituitary mass lesion, cerebral hemisphere and ventricles were normal. Fundus examination revealed chronic papilledema, optic nerve pallor and perimetry showed increased size of blind spot. Neurologist advised preoperative CSF pressure measurement and drainage if pressure is high. CSF manometry was performed in the lateral decubitus position and CSF pressure was more than 250 mm H2O with normal cytological and biochemical profile. 20 mL of CSF was drained with a 22 gauge Quincke's needle. After drainage the CSF pressure was 150 mm H2O. Patient was posted for surgery after 2 days.
On the day of surgery, injection glycopyrrolate (0.2 mg), injection midazolam (2 mg) and injection fentanyl (200 μg) were given intravenously as pre-medication. Anaesthesia was induced with propofol 175 mg and tracheal intubation was facilitated with vecuronium 5 mg injection plain lignocaine 2% 5 ml was given to attenuate pressor response. Anaesthesia was maintained with oxygen, nitrous oxide, propofol infusion, and vecuronium. Intra-operatively injection mannitol 1 g/kg was given. Monitoring included pulse oximetry, electrocardiogram (ECG), noninvasive blood pressure noninvasive blood pressure (NIBP), ETCO2, urine out-put and temperature. At the end of surgery neuro-muscular block was reversed with injection neostigmine 3.5 mg and glycopyrrolate 0.4 mg. She was shifted to post-operative recovery room and monitored for 48 h with pulse oximetry, ECG, NIBP, urine out-put, and temperature. She was completely asymptomatic at discharge.

DISCUSSION

IIH was first described by Quinke in 1893 and was called “serous meningitis.” IIH is caused by dural sinus thrombosis, a reduction in corticosteroid therapy, hormonal imbalance, vitamin A toxicity, anabolic corticosteroids, long-term tetracycline, hormonal contraceptives, lithium, and pregnancy.[] Theories of IIH pathophysiology include increased venous sinus pressure, decreased spinal fluid absorption, increased spinal fluid secretion, increased blood volume and brain oedema.[] The various treatment modalities used in patients include corticosteroids, acetazolamide, diuretics, repeated lumbar puncture and surgery. The goals of treatment of IIH involve a reduction of intracranial pressure to control symptoms and prevent pressure on the optic nerve and optic meninges, preserving vision. Serial lumbar punctures have a success rate of 30-40% when used alone. Generally, up to 30 ml of fluid is withdrawn to lower the intracranial pressure to normal.[] Our patient had a history of IIH since 2 years, was on tablet acetazolamide and showed response to medical therapy. Lumbar puncture was carried out twice to improve symptoms. In our patient, 20 cc of CSF was removed to keep the CSF pressure within normal limits.
From the literature, it has been found that IIH is more common in females in the age group 20-45 years.[] Women with more than 10% over their ideal body weight are 13 times more likely to develop IIH.[] Our patient was having a body mass index of >30 kg/m2. The mechanism proposed is that central obesity raises intra-abdominal pressure, which increases intra-pleural pressure and cardiac filling pressure, which in turn impedes venous return from the brain and leads to increased intracranial venous pressure, and increased intracranial pressure.[]
Neuraxial anaesthesia, spinal or epidural has been used successfully for caesarean section in patients with IIH. Since lumbar puncture for CSF drainage is a therapeutic modality for IIH, there is no indication to withhold spinal anaesthesia in these patients.[] Bedson and Plaat reported the combined spinal-epidural technique for delivery by caesarean section.[] Although, dural puncture is contraindicated in patients with increased intracranial pressure resulting from space occupying lesions due to risk of uncal herniation. However, it has been postulated that the uniform swelling and stiffness of the brain in IIH prevents herniation.[] Aly and Lawther reported a case of uncontrolled IIH successfully managed using an epidural catheter for analgesia in labour and delivery as well as temporary control of intracranial pressure.[] Abouleish and Ali had given spinal anaesthesia for caesarean section in patient with IIH.[]
In our patient, both surgeries were carried out simultaneously, so we had no option for regional anaesthesia. We have selected general anaesthesia as nephrectomy was carried out in the lateral decubitus position. If a patient with IIH requires general anaesthesia, the planned approach should minimize the risk of a rise in intracranial pressure associated with intubation, inadequate depth of anaesthesia and extubation. So, we have to take measures to avoid an increase in intracranial pressure (ICP) during the peri-operative period.
Propofol offers a number of pharmacological advantages for total intravenous anaesthesia in patients of raised ICP. It decreases cerebral blood flow and cerebral oxygen consumption and increases cerebrovascular resistance. It could offer cerebral protection.[] The synthetic short acting opioids like fentanyl lack any significant effect on ICP.
Induction and intubation may aggravate intracranial hypertension. Liberal doses of propofol combined with narcotics to achieve adequate depth of anaesthesia, mild to moderate hyperventilation, intravenous lignocaine bolus are the measures that prevent dangerous increase in ICP. We induced the patient with (200 μg) fentanyl and propofol and avoided succinylcholine for intubation as muscle fasciculation caused by succinylcholine, increase the intra cerebral blood volume and increase the ICP. Intubation in lighter planes of anaesthesia should be avoided. Atracurium causes histamine release, slightly increases the pulse rate and central system excitement, so we have used vecuronium in our patient. Vecuronium does not alter ICP or CSF dynamics and lack of cerebral effects have made vecuronium a popular choice in patients with raised ICP. Definitive measures used for decreasing the ICP include, mild head elevation, maintain EtCO2 between 25 mmHg and 30 mmHg, I.V. mannitol, continuous infusion of thiopentone or propofol, avoid hypoxia, hypercarbia, hyperthermia and hypotension.

CONCLUSION

In conclusion, although IIH is rare, there are special considerations for anaesthetic management in patients with this disorder. Even though, these patients have an elevated ICP, anaesthesia does not cause any detrimental effects in patients with IIH. So, we have to take measures to avoid increase in ICP during the perioperative period. Despite the presence of raised ICP in these patients, there is no specific contraindication to either spinal or epidural anaesthetic technique since uncal herniation does not occur in these patients. The main goal is to avoid further increases in ICP.

Wednesday, January 11, 2012

Anaesthetic management in a patient with multiple sclerosis

Anaesthetic management in a patient with multiple sclerosis


Department of Anaesthesiology, KLE University's, Jawaharlal Nehru Medical College & KLES Dr. Prabhakar Kore Hospital, Nehru Nagar, Belgaum, India

   Introduction Top


Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS) with genetic predisposition characterized by a wide variety of neurological impairment and symptoms due to multi-focal areas of inflammation and demyelination in brain and spinal cord. [1],[2] The treatment is symptomatic and with immunosuppressant drugs as there is no cure for MS. 

Prevalence, increases with latitude, is rare in Asian countries, highest in north Scotland, northern Europe, and northern United States and in Canada. [1] 

Exact prevalence in India is not available, but occasionally an anaesthesiologist may encounter a case of MS. 


   Case Report Top


A boy of sixteen years who was a known case of MS for past eight years presented with fracture shaft of femur following a sudden fall while on treatment of MS following a relapse and was scheduled to undergo open reduction, internal fixation. He had history of limb weakness, relapsing--remitting type with movement-induced muscle spasms, gradually progressing in all the four limbs. During past two months there was diminution of vision in both the eyes and he was restricted to bed. Bowel and bladder function was normal. There was no history of seizures, difficulty in speech, swallowing and breathing. On examination he was moderate in built, weighed 38 kg with normal pulse, blood-pressure, respiration and temperature. 

CNS examination revealed a conscious patient with normal higher functions, but mentally depressed. Speech was normal. There was loss of power in all the four limbs, 2/5 in both upper limbs and 2/5 in right lower limb (left lower limb with fracture) as per Medical Research Council (MRC) rating. Co-ordination was impaired in upper and lower limbs with marked movement-induced spasticity, hyper responsive deep reflexes and up-going Babinski. He also had optic neuritis. Gait could not be tested. His sensory system, other cranial nerves, brain-stem function appeared normal. Heart-rate response to deep breathing was normal. His other systems were normal. 

Laboratory investigations (routine haematological, liver and kidney function, serum electrolytes), chest X-ray and electrocardiogram (ECG) were normal.

Magnetic resonance imaging (MRI) scan showed patchy bright signals within the cord on T 2 -weighed images from C 1 to T 10 vertebral levels suggesting demyelination. No focal lesion of brain parenchyma was seen. 

He was receiving oral methotrexate and folic acid, oral baclofen and methylcobalamin for last six years. Recently, he was treated with intravenous (I.V.) methyl prednisolone during an acute attack followed by tapering dose of oral prednisolone, during last 6-8 weeks.


Saturday, June 18, 2011

Alzheimer's Disease and Anesthesia


Alzheimer's Disease
Alzheimer's disease is a chronic neurodegenerative disorder. It is the most common cause of dementia in patients older than 65 years of age, and the fourth most common cause of death from disease in patients older than 65. Diffuse amyloid-rich senile plaques and neurofibrillary tangles are the hallmark pathologic findings. There are also changes in synapses and the activity of multiple major neurotransmitters, especially involving acetylcholine and central nervous system nicotinic receptors. Two types of Alzheimer's disease have been described: early onset and late onset. Early-onset Alzheimer's disease usually presents before age 60 and is thought to be due to missense mutations on up to three genes leading to an autosomal dominant mode of transmission. Late-onset Alzheimer's disease usually develops after age 60, and genetic transmission appears to play a relatively minor role in the risk of developing this disorder. With both forms of the disease, patients typically develop progressive cognitive impairment that can consist of problems with memory as well as apraxia, aphasia, and agnosia. Definitive diagnosis is usually made on postmortem examination, usually making premortem diagnosis of Alzheimer's disease one of exclusion. There is currently no cure for Alzheimer's disease, and treatment usually focuses on control of symptoms. Pharmacologic options include cholinesterase inhibitors, such as tacrine, donepezil, rivastigmine, and galantamine. Pharmacologic therapy should be combined with nonpharmacologic therapy including caregiver education and family support. Despite treatment, the prognosis for patients with Alzheimer's disease is poor.
Patients with Alzheimer's disease may present for a variety of surgical interventions that are common in the elderly population. Patients are often confused and sometimes uncooperative, making monitored anesthesia care or regional anesthesia challenging. However, there is probably no one single anesthesia technique or agent that is superior in this group of patients. Shorter acting sedative/hypnotic drugs, anesthetic agents, and narcotics are preferred since they may allow a more rapid return to baseline mental status. Finally, one should be aware of potential drug interactions, especially prolongation of the effect of succinylcholine and relative resistance to nondepolarizing muscle relaxants due
to the use of cholinesterase inhibitors.